Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
0%Inventory to Assets Ratio
VS
Market
Sector
Industry
History
$ 14.26Close
$ 8.21 - $ 14.6 52-Week Range
Ticker Information
Ticker
TBPHCompany Name
THERAVANCE BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTHERAVANCE BIOPHARMA INC - Inventory to Assets Ratio Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TBPH - Inv. to Assets Historical data
| Date | Total Assets | Inventory | Inventory to Assets Ratio |
|---|---|---|---|
| 6/30/2025 | $ 426.04M | $ 0 | 0% |
| 3/31/2025 | $ 343.58M | $ 0 | 0% |
| 12/31/2024 | $ 354.16M | $ 0 | 0% |
| 9/30/2024 | $ 356.11M | $ 0 | 0% |
| 6/30/2024 | $ 362.03M | $ 0 | 0% |
| 3/31/2024 | $ 371.31M | $ 0 | 0% |
| 12/31/2023 | $ 382M | $ 0 | 0% |
| 9/30/2023 | $ 413.59M | $ 0 | 0% |
| 6/30/2023 | $ 446.63M | $ 0 | 0% |
| 3/31/2023 | $ 538.55M | $ 0 | 0% |
Key Performance Insights, Last 5 Years
- THERAVANCE BIOPHARMA INC's latest trailing twelve months (TTM) Inv. to Assets stands at 0%.
- Over the past 5 years, THERAVANCE BIOPHARMA INC's average Inv. to Assets has been 0%.
- The median Inv. to Assets for THERAVANCE BIOPHARMA INC during this period was 0%
- THERAVANCE BIOPHARMA INC reached its highest Inv. to Assets over the past 5 years at 0%.
- The lowest Inv. to Assets recorded by THERAVANCE BIOPHARMA INC in the same timeframe 0%
THERAVANCE BIOPHARMA INC's Inv. to Assets vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inv. to Assets Benchmarks
Similar metrics to Inv. to Assets:
- Inventory - [Balance Sheet] Inventory is a component of [Assets] that represents the expected market value of inventories in all stages of completion.
- Quick Ratio - [Calculation] The quick ratio is a liquidity indicator that describes the company’s ability to pay short-term obligations without the need to sell its inventory or receive additional financing. Calculated by dividing current assets [AssetsC] minus [Inventory] by current liabilities [LiabilitiesC].
- Debt to Assets Ratio - [Calculation] Debt to Assets measures the ratio between a company’s [Liabilities] and [Assets]. A high ratio might indicate more risk.
- Cash to Assets Ratio - [Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
- Total Assets - [Balance Sheet] An asset represents anything that has current and/or future economic value to a company. This includes Cash [CashnEq], [Investments], [Intangibles], [Receivables] and more.
Definition of Inventory to Assets Ratio
[Calculation] [Inventory] as percentage of total [Assets], serves as an efficiency ratio - the lower the better.Inventory / Assets
(=) Inv. to Assets Inv. to Assets for THERAVANCE BIOPHARMA INC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 512.19M ]
(=) Inv. to Assets [ 0% ] TBPH - Inventory to Assets Ratio, Last 5 years
0%
Minimum
Sep 30, 2020
0%
Maximum
Sep 30, 2020
0%
Average
0%
Median
Inv. to Assets Benchmark AnalysisMarket
The chart above depicts the distribution of Inv. to Assets for companies in the Total Stock Market. The average Inv. to Assets of the companies is 6.08% with a standard deviation of 11.11%.
The following table provides additional summary stats:
Inv. to Assets in the Market:
| filtered constituents | 4.46K |
|---|---|
| min | 0% |
| max | 98.39% |
| average | 6.08% |
| median | 0% |
| std | 11.11% |